Company Profile

Akari Therapeutics Plc (NASDAQ: AKTX)
5:30 PM UTC, 07/03/24
Last: $3.18 Change: +0.08 %Change: +2.64% Volume: 2,374
Detailed Quote
Open: $ 3.23   Volume: 2,374
High: $ 3.31   Yield(%) 0.00
Low: $ 3.10   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 24.56M
EPS ($) -3.86   Shares Out: 7.92M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): 60.62
% Price Change (last 13 weeks): 105.30
% Price Change (last 26 weeks): 7.02
% Price Change (last 52 weeks): -6.40
% Price Change (year to date): -0.64
Management Effectiveness
Return on Equity (%): -1281.64
Return on Assets (%): -110.06
Return on Invested Capital (%): -1000.46
Profitability
Gross Profit Margin (%): n/a
Net Profit Margin (%): n/a
Operating Profit Margin (%): 0.00
Price & Volume
50-day Moving Average: $2.06
200-day Moving Average: $2.57
Avg. Daily Vol. (last 50 days): 27,865
Avg. Daily Vol. (last 200 days): 15,928
52-wk high: $5.50
52-wk low: $1.08
Bid: $3.04
Ask: $3.91
Company Information
Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. The company was founded on October 7, 2004 and is headquartered in Boston, MA.
Akari Therapeutics Plc
22 Boston Wharf Road 7th Floor
Boston MA 02210

Phone: 1.929.274.7510
Fax: n/a
http://www.akaritx.com
Per Share Data
Earnings (1year) ($): n/a
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): -0.03
Cash Flow ($): -1.51
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): n/a
Price/Book (x): n/a
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 0.95
Current Ratio (x): 0.95
LT Debt/Equity (x): n/a
Total Debt/Equity (x): n/a



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.